Pivot Bio
Emeryville, US · Founded 2011 · Delaware corporation · 307 employees on LinkedIn · 17 known investors
Find your way into Pivot Bio
403 people in our graph share verified history with the Pivot Bio team — schools, employers, funds. One of them is your warm intro.
Pivot Bio develops agricultural innovations focused on transforming farming practices through microbiology and genetics. The company serves farmers worldwide.
Also known as Pivot Bio, Inc.
Founders & leadership
Pivot Bio was founded in 2011 by Alvin Tamsir and Karsten Temme.


Board


Investors · 17
Also in the syndicate · 5
Reported raises · per SEC filings
Form D private placements$622.6M disclosed across 5 of 6 rounds · 2014–2021
▶$434.5MraisedAug 2021 · 19 investors · Other TechnologyRule 506(b)
- Christopher AbbottDirector
- Ryan RakestrawDirector
- Matt OckoDirector
- Charles Cooper RinzlerDirector
- Alvin TamsirExecutive Officer, Director
- Lisa SafarianDirector
- Karsten TemmeExecutive Officer, Director
- Offering amount
- $435M
- Amount sold
- $434.5M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$100MraisedMay 2020 · 13 investors · Other TechnologyRule 506(b)
- Dheeraj MehtaDirector
- Matt OckoDirector
- Roger WyseDirector
- Alvin TamsirExecutive Officer, Director
- Karsten TemmeExecutive Officer, Director
- Charles Cooper RinzlerDirector
- Offering amount
- $100M
- Amount sold
- $100M
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$71.3MraisedOct 2018 · 15 investors · Other TechnologyRule 506(b)
- Roger WyseDirector
- Karsten TemmeExecutive Officer, Director
- Alvin TamsirExecutive Officer, Director
- Dheeraj MehtaDirector
- Charles Cooper RinzlerDirector
- Matt OckoDirector
- Offering amount
- $71.4M
- Amount sold
- $71.3M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16MraisedMar 2016 · 10 investors · BiotechnologyRule 506(b)
- Alvin TamsirExecutive Officer, Director
- Karsten TemmeExecutive Officer, Director
- Roger WyseDirector
- John HamerDirector
- Matt OckoDirector
- Offering amount
- $16M
- Amount sold
- $16M
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$750KraisedOct 2014 · 1 investors · BiotechnologyRule 506(c)
- Karsten TemmeExecutive Officer, Director
- Alvin TamsirExecutive Officer, Director
- Offering amount
- $1000K
- Amount sold
- $750K
- First sale
- Oct 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026Pivot Bio develops microbial nitrogen products for row crops. Its gene-edited microbes convert atmospheric nitrogen into ammonia directly on a plant's root system, supplying nitrogen through the season as the plant needs it rather than relying solely on soil-applied synthetic fertilizer. The company positions the products as complements to a grower's existing crop nutrition program; PROVEN 40 is stated to replace up to 40 pounds per acre of traditional nitrogen in corn without compromising yield, and the company says farmers can plant seed with up to 25% of the crop's nitrogen needs already in place.
The commercial line spans corn (PROVEN 40, PROVEN G3), wheat and small grains including sorghum, barley, millet, oats and sunflower (RETURN, RETAIN), corn silage, and CERT-N, available in on-seed, in-furrow and dry formulations, with accessory products such as Pivot Bio Extender and NuCore. Products require temperature-controlled dry storage and a single application that fits existing planting equipment; the company provides tank-mix calculators, compatibility guidance and equipment stewardship materials. Pivot Bio also runs the N-OVATOR program, which connects farmers using microbial nitrogen with organizations seeking to reduce on-farm emissions and pays participating growers for improved nitrogen practices.
Founding story
Karsten Temme, Ph.D., is a co-founder and served as CEO, leading the company's development of microbial nitrogen technology as an alternative to synthetic nitrogen fertilizer.
Business model
Pivot Bio manufactures and sells microbial nitrogen products to farmers through a direct-to-grower model rather than traditional fertilizer retail infrastructure, using an on-demand supply chain that ships to growers on their planting timelines. The company has said this approach avoids the factories, pipelines, barges and brick-and-mortar storage associated with synthetic fertilizer, and that advisors can order and schedule delivery via a mobile app.
Revenue comes from sales of microbial nitrogen products (PROVEN, PROVEN 40, PROVEN G3, RETURN, RETAIN, CERT-N) sold per acre to growers, with the company describing recurring, long-term grower relationships. The N-OVATOR program pairs participating farmers with organizations seeking emissions reductions and has paid farmers for improved nitrogen practices.
Traction
Pivot Bio introduced the industry's first commercially available microbial nitrogen in 2019; its inaugural corn product PROVEN sold out in its second commercialization year and was used on hundreds of thousands of U.S. corn acres. In 2021 the company reported use on more than 1 million crop acres, over 300% year-over-year growth, and tripled revenue. The company reports 1,050,000 metric tons of CO2e avoided since 2022 and more than $6 million paid to farmers through the N-OVATOR program since 2022.
Latest developments
In January 2025 the company highlighted a University of Illinois paper describing Pivot Bio as a new source of nitrogen with a unique mode of action, and in January-February 2025 published Northern Plains field results for PROVEN 40 and RETURN OS from the 2024 growing season. The company also notes recognition on TIME magazine's 200 Best Inventions list in two consecutive years and Fast Company's World's Most Innovative Companies of 2024.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
The company describes the synthetic nitrogen fertilizer market it targets as roughly $190-197 billion globally, and has stated it was the only company shipping a synthetic nitrogen fertilizer replacement at scale and the first to bring commercially available microbial nitrogen to market in 2019, as well as the first to introduce on-seed microbial nitrogen in 2022.
Pivot Bio states its microbes are the only ones on the market that convert atmospheric nitrogen to ammonia directly on the plant root, that PROVEN 40 replaces up to 40 pounds per acre of synthetic nitrogen, and that a University of Illinois study confirmed a unique mode of action. Its direct-to-grower supply chain and single-pass on-seed or in-furrow application are also cited as points of difference versus conventional fertilizer distribution.
Technology
The core technology is gene-edited nitrogen-fixing microbes applied on seed or in-furrow that convert atmospheric nitrogen into ammonia on the plant root, delivering nitrogen through the growing season. The company cites proprietary computational and microbiome technologies and multi-scale automated testing in developing its products, and states that production eliminates 99.5% of greenhouse gas emissions relative to synthetic fertilizer manufacturing.
Go-to-market
Direct-to-grower sales supported by company agronomists, an independent sales representative program, and on-demand shipping tied to planting schedules; earlier expansion used on-farm trial programs, including IN10T FarmerTrials for Canadian growers and an early-adopter program for its first wheat product. Agronomic results from field trials and university research are published on the company site.
Row-crop farmers, primarily U.S. corn growers, plus wheat, small grain (sorghum, barley, millet, oats, sunflower) and corn silage producers.
Geography
Operations centered in the United States, with the company historically headquartered in Berkeley, California and listed at a Berkeley address; agronomy results are reported across the Northern Plains (Minnesota, Montana, North Dakota) and Iowa. The company has stated plans to expand internationally, including availability for Argentinian corn farmers and on-farm trials for Canadian growers.
History
The company launched its first commercially available microbial nitrogen product, PROVEN for corn, in 2019, followed by RETURN for U.S. wheat in spring 2020 through a limited early-adopter program. It closed a $100 million Series C in April 2020 and a $430 million Series D in July 2021, by which point it had released four commercial products in three years, including PROVEN 40. In September 2022 it introduced on-seed microbial nitrogen for corn, grain sorghum and spring wheat, and it launched the N-OVATOR program in 2022.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Founder mafia
4 people who came through Pivot Bio went on to found or lead other companies.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2015 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Timeline · 8
launches, deals, and filingsPivot Bio introduced on-seed microbial nitrogen for crops including corn, grain sorghum and spring wheat.
Series D led by DCVC and Temasek, bringing total equity raised to more than $600 million; funds earmarked for scaling the U.S. business and expanding into international markets.
$430M source ↗
Second-generation microbial nitrogen product for corn, the company's fourth commercial release in three years, enabling replacement of up to 40 pounds per acre of synthetic nitrogen.
Company said PROVEN would soon be available to Argentinian corn farmers and that it would launch on-farm corn trials for Canadian growers via IN10T's FarmerTrials.
Series C co-led by returning investors Breakthrough Energy Ventures and Temasek, with DCVC participating materially; company said total raised to date was $186 million.
$100M source ↗
Inaugural wheat product introduced through a limited, early-adopter program in spring 2020.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
Legal entities · 1
corporate structureIn the news
Pivot Bio has raised $70M to sell nitrogen-fixing bacteriaqz.com · Oct 2018▸Research sources · 8
primary sources listed
- Pivot Biopivotbio.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Pivot Bio do?
- Pivot Bio makes gene-edited microbes that fix atmospheric nitrogen on crop roots, replacing part of farmers' synthetic fertilizer.
- Who founded Pivot Bio?
- Pivot Bio was founded by Alvin Tamsir, Karsten Temme in 2011.
- Who are Pivot Bio's investors?
- Pivot Bio's investors include Breakthrough Energy Ventures, Congruent Ventures, DCVC (Data Collective), G2 Venture Partners, K3 Ventures, Manta Ray Ventures, Prelude Ventures, Raptor Group and 4 more.
- How much funding has Pivot Bio raised?
- Pivot Bio has disclosed $622.6M raised across 5 of its 6 known rounds.
- Where is Pivot Bio headquartered?
- Pivot Bio is headquartered in Emeryville, US.





